According to the trends of the innovation and entrepreneurship ecosystem in Latin America, there is an evident accelerated growth in investment with entrepreneurial capital (venture capital) in the last decade, encouraging the development of technologies that achieve 7.5X growth in their valuation.

Life sciences focused on the development of technology and biotechnology with applications in health, well-being and nutrition offer an opportunity for growth and investment due to the knowledge and capabilities of human talent, as well as the richness in the biodiversity of the region.

That is why at Tech Innovation Group  the commitment to the application of knowledge, which arises from research and development processes, is reflected in the effort to multiply investment in early-stage ventures (Company Builder) and growth (acceleration).

In response to this challenge, an investment vehicle is created to finance new companies with active capital to promote their startup and growth. The current goal is to invest US $ 40 million, with a dynamic, flexible and knowledge-based structure, in zebra-type companies with extraordinary growth potential and at the same time committed to social responsibility and environmental protection.

The investment thesis focuses on start-ups in the seed stage and series A, located in Latin America with minority participation. The dispersion of risk seeks to provoke a multiplicative factor in the valuation of the portfolio, operating with allies throughout in the region.